Oncologist Dr. Priya Rudolph of Georgia Cancer Specialists (GCS)—a Top 10 private cancer practice in the U.S.—was recently featured on Barbara Dooley’s WGAU 1340AM radio show. In the April 15th interview, Dr. Rudolph discussed a groundbreaking breast cancer drug called T-DM1 (Kadcyla). The new drug combines an existing cancer medication, Herceptin, with additional powerful toxins to more effectively target cancer cells and reduces side effects.
You can stream the full program here.
he new drug is approved for metastatic HER2-positive breast cancer patients whose disease has progressed following treatment with Herceptin and a taxane chemotherapy drug, such as paclitaxel.
“HER2-positive only accounts for about 25% of all breast cancers,” said Dr. Rudolph. However, “people who have a breast cancer with a HER2 marker on the breast cancer generally have an aggressive tumor that can spread quickly and go to multiple organs.”
The new drug is good news for individuals suffering from this particularly aggressive type of breast cancer and yet another tool available for the GCS oncologists to better serve their patients.
Georgia Cancer Specialists played an integral role in the study that led to the drug’s approval, and was recently selected to be involved in the upcoming trial designed to test T-DM1 in the front line setting.
Georgia Cancer Specialists is a national leader in advanced cancer treatment and research. The practice supports more than 150,000 patient visits each year. GCS offers medical oncology and hematology services as well as a full range of support services for patients in Georgia. GCS physicians were the first in Georgia to offer Phase I clinical trials, the most novel cancer therapies available. GCS 46 medical oncologists practice in 27 Northside Hospital Cancer Institute locations in Metro Atlanta, and North and Central Georgia. The Northside Hospital Cancer Institute is the only comprehensive cancer center in Georgia selected by the National Cancer Institute to participate in the NCI Community Cancer Centers Program (NCCCP). Georgia Cancer Specialists can be found on the web at www.gacancer.com. GCS is The Cancer Answer®.